Literature DB >> 25540029

The EQ-5D-5L index score is more discriminative than the EQ-5D-3L index score in diabetes patients.

Chen-Wei Pan1, Hong-Peng Sun, Xingzhi Wang, Qinghua Ma, Yong Xu, Nan Luo, Pei Wang.   

Abstract

PURPOSE: To compare the discriminative power of the index scores of EQ-5D-5L (5L) and EQ-5D-3L (3L) in diabetes patients in China.
METHODS: A consecutive sample of type 2 diabetes mellitus (T2DM) patients in the clinics self-completed the two versions of EQ-5D. The 3L index score was obtained from the Chinese 3L value set; the 5L index score was predicted from the 3L index score using an interim scoring. Relative efficiency (RE) of the 5L and 3L index scores was calculated to compare their ability in differentiating between T2DM patients with and without one of ten clinical conditions. The efficiency of the 5L and 3L health state classification systems was assessed using the Shannon index (H') and in terms of ceiling effects.
RESULTS: A total of 289 T2DM patients participated in this study. The 5L score was systematically lower than the 3L score for T2DM patients with and without a condition (range -0.36 to -0.06). The 5L score exhibited higher discriminative power in nine of ten conditions, with the mean RE value being 1.92. 5L had higher H' values than 3L in all the five EQ-5D dimensions: mobility (1.14 vs. 0.70), self-care (0.44 vs. 0.33), usual activities (0.72 vs. 0.47), pain/discomfort (1.58 vs. 1.10), and anxiety/depression (1.03 vs. 0.67). The overall ceiling effects decreased from 56.7 % (3L) to 36.7 % (5L).
CONCLUSION: The 5L index score is more discriminative than the 3L index score in T2DM patients and therefore is preferable for use in this population.

Entities:  

Mesh:

Year:  2014        PMID: 25540029     DOI: 10.1007/s11136-014-0902-6

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  33 in total

Review 1.  EQ-5D: a measure of health status from the EuroQol Group.

Authors:  R Rabin; F de Charro
Journal:  Ann Med       Date:  2001-07       Impact factor: 4.709

2.  Characterization and comparison of health-related utility in people with diabetes with various single and multiple vascular complications.

Authors:  C Ll Morgan; P McEwan; M Morrissey; J R Peters; C Poole; C J Currie
Journal:  Diabet Med       Date:  2006-10       Impact factor: 4.359

3.  US valuation of the EQ-5D health states: development and testing of the D1 valuation model.

Authors:  James W Shaw; Jeffrey A Johnson; Stephen Joel Coons
Journal:  Med Care       Date:  2005-03       Impact factor: 2.983

4.  Psychometric comparison of the standard EQ-5D to a 5 level version in cancer patients.

Authors:  A Simon Pickard; Maria C De Leon; Thomas Kohlmann; David Cella; Sarah Rosenbloom
Journal:  Med Care       Date:  2007-03       Impact factor: 2.983

5.  Validation of the EQ-5D in a general population sample in urban China.

Authors:  Hong-Mei Wang; Donald L Patrick; Todd C Edwards; Anne M Skalicky; Hai-Yan Zeng; Wen-Wen Gu
Journal:  Qual Life Res       Date:  2011-04-20       Impact factor: 4.147

Review 6.  The use of the EQ-5D preference-based health status measure in adults with Type 2 diabetes mellitus.

Authors:  M F Janssen; E I Lubetkin; J P Sekhobo; A S Pickard
Journal:  Diabet Med       Date:  2011-04       Impact factor: 4.359

7.  Modelling EuroQol health-related utility values for diabetic complications from CODE-2 data.

Authors:  Adrian Bagust; Sophie Beale
Journal:  Health Econ       Date:  2005-03       Impact factor: 3.046

Review 8.  Health-state utilities in liver disease: a systematic review.

Authors:  David J McLernon; John Dillon; Peter T Donnan
Journal:  Med Decis Making       Date:  2008-04-18       Impact factor: 2.583

9.  Measuring population health: a comparison of three generic health status measures.

Authors:  Susan Macran; Helen Weatherly; Paul Kind
Journal:  Med Care       Date:  2003-02       Impact factor: 2.983

10.  Health-related quality of life in chronic hepatitis B patients.

Authors:  Siew Chin Ong; Belinda Mak; Myat Oo Aung; Shu-Chuen Li; Seng-Gee Lim
Journal:  Hepatology       Date:  2008-04       Impact factor: 17.425

View more
  33 in total

1.  EQ-5D-5L and SF-6D Utility Measures in Symptomatic benign Thyroid Nodules: Acceptability and Psychometric Evaluation.

Authors:  Carlos K H Wong; Brian H H Lang; Hill M S Yu; Cindy L K Lam
Journal:  Patient       Date:  2017-08       Impact factor: 3.883

2.  Validity of the EQ-5D-5L and EQ-5D-3L in patients with Crohn's disease.

Authors:  Fanni Rencz; Peter L Lakatos; László Gulácsi; Valentin Brodszky; Zsuzsanna Kürti; Szilvia Lovas; János Banai; László Herszényi; Tamás Cserni; Tamás Molnár; Márta Péntek; Károly Palatka
Journal:  Qual Life Res       Date:  2018-09-17       Impact factor: 4.147

3.  Normative values of EQ-5D-5L: in a Spanish representative population sample from Spanish Health Survey, 2011.

Authors:  M A Garcia-Gordillo; J C Adsuar; P R Olivares
Journal:  Qual Life Res       Date:  2015-10-19       Impact factor: 4.147

4.  Validation and comparison of the psychometric properties of the EQ-5D-3L and EQ-5D-5L instruments in Greece.

Authors:  John N Yfantopoulos; Athanasios E Chantzaras
Journal:  Eur J Health Econ       Date:  2016-06-04

5.  Responsiveness of the EuroQoL 5-dimension (EQ-5D) in adolescent idiopathic scoliosis.

Authors:  Prudence Wing Hang Cheung; Carlos King Ho Wong; Sin Ting Lau; Jason Pui Yin Cheung
Journal:  Eur Spine J       Date:  2017-10-09       Impact factor: 3.134

6.  Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L in psoriasis patients.

Authors:  Adrienn Katalin Poór; Fanni Rencz; Valentin Brodszky; László Gulácsi; Zsuzsanna Beretzky; Bernadett Hidvégi; Péter Holló; Sarolta Kárpáti; Márta Péntek
Journal:  Qual Life Res       Date:  2017-09-05       Impact factor: 4.147

7.  Comparing the measurement properties of the EQ-5D-5L and the EQ-5D-3L in hypertensive patients living in rural China.

Authors:  Jie Jiang; Yanming Hong; Tiantian Zhang; Zhihao Yang; Tengfei Lin; Zhuoru Liang; Peiyao Lu; Lishun Liu; Binyan Wang; Yongmei Xu; Nan Luo
Journal:  Qual Life Res       Date:  2021-04-05       Impact factor: 4.147

8.  EQ-5D-5L is More Responsive than EQ-5D-3L to Treatment Benefit of Cataract Surgery.

Authors:  Mihir Gandhi; Marcus Ang; Kelvin Teo; Chee Wai Wong; Yvonne Chung-Hsi Wei; Rachel Lee-Yin Tan; Mathieu F Janssen; Nan Luo
Journal:  Patient       Date:  2019-08       Impact factor: 3.883

9.  Comparing EQ-5D-3L and EQ-5D-5L performance in common cancers: suggestions for instrument choosing.

Authors:  Juan Zhu; Xin-Xin Yan; Cheng-Cheng Liu; Hong Wang; Le Wang; Su-Mei Cao; Xian-Zhen Liao; Yun-Feng Xi; Yong Ji; Lin Lei; Hai-Fan Xiao; Hai-Jing Guan; Wen-Qiang Wei; Min Dai; Wanqing Chen; Ju-Fang Shi
Journal:  Qual Life Res       Date:  2020-09-15       Impact factor: 4.147

10.  A Head-to-Head Comparison of the EQ-5D-5L and AQoL-8D Multi-Attribute Utility Instruments in Patients Who Have Previously Undergone Bariatric Surgery.

Authors:  Julie A Campbell; Andrew J Palmer; Alison Venn; Melanie Sharman; Petr Otahal; Amanda Neil
Journal:  Patient       Date:  2016-08       Impact factor: 3.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.